---
title: A case of T-cell acute lymphoblastic leukemia in retroviral gene therapy for
  ADA-SCID
date: '2024-04-30'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38688902/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240501181354&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Hematopoietic stem cell gene therapy (GT) using a γ-retroviral vector
  (γ-RV) is an effective treatment for Severe Combined Immunodeficiency due to Adenosine
  Deaminase deficiency. Here, we describe a case of GT-related T-cell acute lymphoblastic
  leukemia (T-ALL) that developed 4.7 years after treatment. The patient underwent
  chemotherapy and haploidentical transplantation and is currently in remission. Blast
  cells contain a single vector insertion activating the LIM-only protein 2 ...
disable_comments: true
---
Hematopoietic stem cell gene therapy (GT) using a γ-retroviral vector (γ-RV) is an effective treatment for Severe Combined Immunodeficiency due to Adenosine Deaminase deficiency. Here, we describe a case of GT-related T-cell acute lymphoblastic leukemia (T-ALL) that developed 4.7 years after treatment. The patient underwent chemotherapy and haploidentical transplantation and is currently in remission. Blast cells contain a single vector insertion activating the LIM-only protein 2 ...